| |
|
|
|
Zymeworks Announces Plan To Become A Delaware Corporation
|
|
Vancouver, BC, July 25, 2022--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, has announced its intention to become a Delaware corporation ("New Zymeworks"), subject to receipt of necessary shareholder, stock exchange, and court approvals.
|
|
|
|
|
|
|
|
Zymeworks Appoints Dr. Paul Moore As Chief Scientific Officer
|
|
Vancouver, BC, July 21, 2022--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, announced that it is strengthening its senior leadership team with the appointment of Paul Moore, Ph.D., as Chief Scientific Officer, reporting directly to the Chief Executive Officer.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zymeworks Names Neil Josephson, M.D., Chief Medical Officer
|
|
Vancouver, BC, November 22, 2021--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced that Neil Josephson, M.D., who has been serving as the company's interim Chief Medical Officer (CMO) since May of this year, will transition to the permanent CMO position, effective November 15.
|
|
|
|
|
|
|
|
|
|
Zymeworks Reports 2020 Year-End Financial Results
|
|
Vancouver, BC, March 1, 2021--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, reported financial results for the year ended December 31, 2020 and provided a summary of recent business and clinical highlights.
|
|
|
|
|
|
|
|
Zymeworks Expands Commercial Team and Creates New R&D Role
|
|
Vancouver, BC, February 10, 2021--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced that James Priour, former Senior Vice President, Commercial, has been promoted to Chief Commercial Officer and named to the Company's Executive Committee.
|
|
|
|
|
News
Events
Tech Careers
Directory
Tech Stocks
T-Net 100
Members
Feedback
About T-Net
Employers
Post Job Listings
Advertise
